Cargando…

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii

PURPOSE: Due to its ability to disseminate worldwide and its multiple resistance trait, Acinetobacter baumannii is becoming a threat for public health worldwide. Cefiderocol (FDC) is a promising broad-spectrum cephalosporin recently approved for treating Gram-negative infection. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raro, Otávio Hallal Ferreira, Bouvier, Maxime, Kerbol, Auriane, Decousser, Jean-Winoc, Poirel, Laurent, Nordmann, Patrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651535/ https://www.ncbi.nlm.nih.gov/pubmed/37910268 http://dx.doi.org/10.1007/s10096-023-04691-w

Ejemplares similares

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer
por: Hallal Ferreira Raro, Otávio, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii Clone, France
por: Bonnin, Rémy A., et al.
Publicado: (2013)

Worldwide Dissemination of the bla(OXA-23) Carbapenemase Gene of Acinetobacter baumannii(1)
por: Mugnier, Pauline D., et al.
Publicado: (2010)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
por: Le, Casin, et al.
Publicado: (2022)

The Iron Content of Human Serum Albumin Modulates the Susceptibility of Acinetobacter baumannii to Cefiderocol
por: Escalante, Jenny, et al.
Publicado: (2023)

Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
por: Fournier, Pierre-Edouard, et al.
Publicado: (2006)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa
por: Sadek, Mustafa, et al.
Publicado: (2022)

Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
por: Nordmann, Patrice, et al.
Publicado: (2023)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates
por: Ballesté-Delpierre, Clara, et al.
Publicado: (2022)

Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection
por: Mabayoje, Diana A, et al.
Publicado: (2021)

Complete Genome Sequence of the Clinical Strain Acinetobacter baumannii R2090 Carrying the Chromosomally Encoded Metallo-β-Lactamase Gene bla(NDM-1)
por: Krahn, Thomas, et al.
Publicado: (2015)

Rapid Detection of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2012)

Resistance to ceftazidime-avibactam in a KPC-2–producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25
por: Findlay, Jacqueline, et al.
Publicado: (2023)

2759. Cefiderocol vs Best Available Therapy for the Treatment of Carbapenem- Resistant Acinetobacter baumannii
por: Daisey, Gabrielle N, et al.
Publicado: (2023)

Rapid Detection of ESBL-Producing Enterobacteriaceae in Blood Cultures
por: Dortet, Laurent, et al.
Publicado: (2015)

Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2016)

Rapid detection of temocillin resistance in Enterobacterales
por: Findlay, Jacqueline, et al.
Publicado: (2023)

Carbapenemase-producing Acinetobacter spp. in Cattle, France
por: Poirel, Laurent, et al.
Publicado: (2012)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei
por: Siméon, Soline, et al.
Publicado: (2020)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
por: Seifert, Harald, et al.
Publicado: (2023)

Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
por: Mezcord, Vyanka, et al.
Publicado: (2023)

2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains
por: Iovleva, Alina, et al.
Publicado: (2023)

Complete Genome Sequence of Acinetobacter baumannii CIP 70.10, a Susceptible Reference Strain for Comparative Genome Analyses
por: Krahn, Thomas, et al.
Publicado: (2015)

Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii
por: Liu, Xiaochen, et al.
Publicado: (2023)

An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates
por: Aubry, Romain, et al.
Publicado: (2023)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
por: Carcione, Davide, et al.
Publicado: (2021)

666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study
por: Marcella, Stephen, et al.
Publicado: (2022)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii
por: Kolesnik-Goldmann, Natalia, et al.
Publicado: (2023)

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials
por: Nordmann, Patrice, et al.
Publicado: (2022)

VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France
por: Naas, Thierry, et al.
Publicado: (2006)

Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
por: Gaillot, Susie, et al.
Publicado: (2023)

Susceptibility Patterns of Multidrug-Resistant Acinetobacter baumannii
por: Konca, Capan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5e6qvdeoscdlibbu34bllj36c